Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Lactobacillus gasseri BNR17 and Reduced Body Weight

Research synthesisLow evidenceSmall effect3 studies · 1 beneficial · 2 neutral · 0 harmful

Across 3 studies (1 beneficial, 2 neutral), the evidence for Lactobacillus gasseri BNR17 reducing body weight is mixed, with a predominant small effect size. The only statistically significant finding came from a meta-analysis that included multiple Lactobacillus species, while two direct RCTs of BNR17 found no significant weight change. The most commonly studied dose was 10^10 CFU/day in one trial, and all studies involved obese adults.

  • Studied populations: obese adults

Caveats: Evidence base is small (only 3 studies) — conclusions should be considered preliminary. Only 1 of the 3 studies reached statistical significance, and it was a meta-analysis that included multiple Lactobacillus strains, not exclusively BNR17. The two direct RCTs of BNR17 found no significant effect on body weight, suggesting the modest benefit may not be specific to this strain.

Generated Jul 12, 2026
Doses used in studies
  • CFU/day: 10 billion (median 10 billion, IQR 10 billion10 billion) 1 study
Safety in these studies
4 of 4 papers
Back to top